GlassScriptPhysician profile
Lauren Bowen
NPI 1356781843
$126,860.75
in general payments reported to CMS, 2019-2025
64 companies · $62K in 2025
The $62K reported for 2025 was more than what 99% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,847 · 2020: $2,914 · 2021: $2,413 · 2022: $7,489 · 2023: $4,168 · 2024: $46K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $97K · Food and Beverage: $8,892 · Travel and Lodging: $6,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $96,781.25 |
| Food and Beverage | $8,892.25 |
| Travel and Lodging | $6,523.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $115,026.79 | 2019-2025 | Botox, Ubrelvy, Qulipta |
| Allergan, INC. | $1,363.96 | 2019-2022 | |
| Upsher-Smith Laboratories LLC | $1,202.26 | 2019-2023 | |
| Amgen INC. | $1,177.34 | 2019-2023 | Aimovig |
| Pfizer INC. | $918.63 | 2023-2025 | |
| Lundbeck LLC | $548.35 | 2020-2025 | Vyepti, Rexulti |
| Tonix Medicines, INC. | $498.34 | 2024-2025 | Zembrace Symtouch |
| Lilly USA, LLC | $456.33 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Impel Pharmaceuticals INC. | $428.88 | 2023 | Trudhesa |
| Currax Pharmaceuticals LLC | $417.31 | 2020-2025 | Onzetra Xsail |
| Teva Pharmaceuticals USA, INC. | $333.21 | 2019-2024 | Ajovy, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $300.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $263.29 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $230.95 | 2022 | |
| Bausch Health US, LLC | $229.86 | 2019 |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.